|
|
|
Biological Activity:
Highly potent and selective δ opioid receptor agonist with Ki value to be 0.84 nM and ED50 value to be 20 nM.
References:
B Le Bourdonnec et al. Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859). J. Med. Chem. 2008, 51(19), 5893-5896. [online]
Chemical Name: N,N-Diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide |
| ADL 5859 | Delta opioid agonist | Axon Medchem | Axon 1751 | ADL5859 |
|
axonmedchem.com © 2012 |
![]() |
Axon Opioid Receptor Ligands:
ADL 5859 | δ opioid agonist
Fedotozine | k opioid agonist
SNC 80 | δ opioid agonist
U 50488 | k opioid agonist
nor-BNI | k opioid antagonist
β-FNA | μ opioid antagonist
GNTI | k opioid antagonist
Nalmefene | opioid antagonist
Naloxonazine | opioid antagonist
Naloxone Benzoylhydrazone
BAN ORL 24 | NOP antagonist
JTC 801 | NOP antagonist
SB 612111 | NOP antagonist |